253 related articles for article (PubMed ID: 9701451)
1. Anticoagulant effects of synthetic retinoids and activated vitamin D3.
Koyama T; Hirosawa S
Semin Thromb Hemost; 1998; 24(3):217-26. PubMed ID: 9701451
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant effects of synthetic retinoids.
Koyama T; Shibakura M
Leuk Lymphoma; 1998 Sep; 31(1-2):71-80. PubMed ID: 9720716
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulant effects of synthetic retinoids mediated via different receptors on human leukemia and umbilical vein endothelial cells.
Shibakura M; Koyama T; Saito T; Shudo K; Miyasaka N; Kamiyama R; Hirosawa S
Blood; 1997 Aug; 90(4):1545-51. PubMed ID: 9269772
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulant effects of retinoic acids on leukemia cells.
Saito T; Koyama T; Nagata K; Kamiyama R; Hirosawa S
Blood; 1996 Jan; 87(2):657-65. PubMed ID: 8555488
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant effects of 1alpha,25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes.
Koyama T; Shibakura M; Ohsawa M; Kamiyama R; Hirosawa S
Blood; 1998 Jul; 92(1):160-7. PubMed ID: 9639512
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction pathways underlying the expression of tissue factor and thrombomodulin in promyelocytic cells induced to differentiate by retinoid acid and dibutyryl cAMP.
López-Pedrera C; Dobado-Berrios PM; Ros R; Torres A; García-Navarro S; Jardí M; Félez J; Velasco F
Thromb Haemost; 2001 Jun; 85(6):1031-6. PubMed ID: 11434680
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells.
Zhuang Y; Faria TN; Chambon P; Gudas LJ
Mol Cancer Res; 2003 Jun; 1(8):619-30. PubMed ID: 12805409
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
[TBL] [Abstract][Full Text] [Related]
10. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
[TBL] [Abstract][Full Text] [Related]
11. Promyelocytic leukemia retinoid signaling targets regulate apoptosis,tissue factor and thrombomodulin expression.
López-Pedrera C; Barbarroja N; Buendía P; Torres A; Dorado G; Velasco F
Haematologica; 2004 Mar; 89(3):286-95. PubMed ID: 15020266
[TBL] [Abstract][Full Text] [Related]
12. [Retinoid signalling pathways].
Fukasawa H; Shudo K
Gan To Kagaku Ryoho; 1993 Apr; 20(5):555-66. PubMed ID: 8470912
[TBL] [Abstract][Full Text] [Related]
13. Cooperative action of 1alpha,25-dihydroxyvitamin D3 and retinoic acid in NB4 acute promyelocytic leukemia cell differentiation is transcriptionally controlled.
Bastie JN; Balitrand N; Guillemot I; Chomienne C; Delva L
Exp Cell Res; 2005 Nov; 310(2):319-30. PubMed ID: 16181625
[TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE
Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735
[TBL] [Abstract][Full Text] [Related]
15. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
16. All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells.
Koyama T; Hirosawa S; Kawamata N; Tohda S; Aoki N
Blood; 1994 Nov; 84(9):3001-9. PubMed ID: 7949172
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
Botling J; Oberg F; Törmä H; Tuohimaa P; Bläuer M; Nilsson K
Cell Growth Differ; 1996 Sep; 7(9):1239-49. PubMed ID: 8877104
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of thrombomodulin antigen levels in U937 cells by combined stimulation with estradiol-17beta and vitamin K2 (menaquinone 4).
Nishiguchi T; Kobayashi T; Sugimura M; Kobayashi H; Terao T
Semin Thromb Hemost; 1999; 25(5):509-17. PubMed ID: 10625211
[TBL] [Abstract][Full Text] [Related]
19. Different combinations of retinoids and vitamin D3 analogs efficiently promote growth inhibition and differentiation of myelomonocytic leukemia cell lines.
Defacque H; Dornand J; Commes T; Cabane S; Sevilla C; Marti J
J Pharmacol Exp Ther; 1994 Oct; 271(1):193-9. PubMed ID: 7965714
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.
Géhin M; Vivat V; Wurtz JM; Losson R; Chambon P; Moras D; Gronemeyer H
Chem Biol; 1999 Aug; 6(8):519-29. PubMed ID: 10421757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
